Abbott Labs Takes On Sandoz Over Generic Biaxin XL

Law360, New York (September 27, 2005, 12:00 AM EDT) -- Abbott Laboratories has sued European generic maker Sandoz over its plans to make a generic version of the antibiotic Biaxin XL.

The complaint claims that Sandoz’s generic version of the drug will “result in irreparable harm to Abbott that cannot be compensated by monetary damages.”

Biaxin XL is a form of clarithromycin used to treat bacterial infections of the respiratory tract. Biaxin XL is the time release variation of the drug Biaxin, for which Abbott also holds the patents.

Total annual market sales for oral clarithromycin...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.